Planchard D, Wolf J, Solomon B, Sebastian M, et al. A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer. Lung Cancer 2024;197:107964.
PMID: 39383771